Drugs / Live F tularensis Vaccine
Live F tularensis Vaccine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00584844 | Oct 2004 → Oct 2009 | tularemia | U.S. Army Medical Research and Development Command | Completed | No outcome recorded |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Live F tularensis Vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00584844 ↗ |
| Known as | F tularensis vaccine | “Subjects will receive one drop of reconstituted F tularensis vaccine (approximately 0.0025 ml), applied with a bifurcated needle to the volar surface of the forearm, and the...” NCT00584844 ↗ |
| Known as | Live Francisella tularensis Vaccine | “This study is designed to determine the safety and immunogenicity of a Live Francisella tularensis Vaccine” NCT00584844 ↗ |
| Known as | NDBR 101 | “A Longitudinal Phase 2 Study for the Continued Evaluation of the Safety and Immunogenicity of a Live Francisella Tularensis Vaccine, NDBR 101, Lot 4” NCT00584844 ↗ |
| Modality | Vaccine | “Live Francisella tularensis Vaccine” NCT00584844 ↗ |